Clinical benefit of adjuvant chemotherapy in resected T2N0 distal cholangiocarcinoma: a retrospective cohort study
Open Access
- 1 January 2026
- journal article
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 111 (3) , 139-147
Abstract
Chae YS, et al. Ann Surg Treat Res. 2026 Sep;111(3):139-147. https://doi.org/10.4174/astr.2026.111.3.139Keywords
This publication has 28 references indexed in Scilit:
- Role of Adjuvant Chemotherapy in Distal CholangiocarcinomaJournal of Hepato-Biliary-Pancreatic Sciences, 2025
- Subdivision of pT1N0 (American Joint Committee on Cancer 8th edition) distal cholangiocarcinoma for adjuvant chemotherapy considerationJournal of Hepato-Biliary-Pancreatic Sciences, 2024
- Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2022
- Spread of lymph node metastasis and adjuvant therapy for distal cholangiocarcinomaInternational Journal of Clinical Oncology, 2022
- Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched AnalysisJournal of Gastrointestinal Surgery, 2018
- Reappraisal of classification of distal cholangiocarcinoma based on tumour depthBritish Journal of Surgery, 2018
- Prognostic predictability of the new American Joint Committee on Cancer 8th staging system for distal bile duct cancer: limited usefulness compared with the 7th staging systemJournal of Hepato-Biliary-Pancreatic Sciences, 2017
- Recurrence after resection with curative intent for distal cholangiocarcinomaBritish Journal of Surgery, 2017
- Biliary tract cancer registry in Japan from 2008 to 2013Journal of Hepato-Biliary-Pancreatic Sciences, 2015
- Impact of intrapancreatic or extrapancreatic bile duct involvement on survival following pancreatoduodenectomy for common bile duct cancerBritish Journal of Surgery, 2014